Pharmaceuticals, Biotechnology and Life Sciences
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that a 1-for-12…
VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx’s VYVGART® and VYVDURA portfolio…
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (the “Company”), a company focused on…
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global…
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) — Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada,…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), announced that AutoMax Motors…